Yidu Tech secures RMB4.09 million contract to provide SMO technical services for PIONEER2 clinical trial

Bulletin Express

04/28

Hong Kong–listed Yidu Tech announced that its affiliate, Yidu Cloud (Beijing) Technology Co., Ltd., has won the bid to deliver site management organization (SMO) technical services for the PIONEER2 clinical trial at the First Affiliated Hospital of Guangzhou Medical University.

The contract value is approximately RMB4.09 million, underscoring continued commercial traction for Yidu Tech’s data-driven healthcare solutions.

According to the announcement, Yidu Tech leverages artificial intelligence trained on real-world clinical data to streamline decision-making for physicians, pharmaceutical companies, insurers and patients. The PIONEER2 engagement reflects the company’s strategy of embedding proprietary AI capabilities across the healthcare value chain to accelerate precision medicine adoption in China.

The Board is chaired by Executive Director Ms. Gong Yingying, with the voluntary announcement dated 28 April 2026.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1192500227"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1192500227\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1192500227?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-28 21:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1192500227","market":"us","top_or_hot":-1,"title":"Yidu Tech secures RMB4.09 million contract to provide SMO technical services for PIONEER2 clinical trial","media":"Bulletin Express","content":"<p>Hong Kong–listed Yidu Tech announced that its affiliate, Yidu Cloud (Beijing) Technology Co., Ltd., has won the bid to deliver site management organization (SMO) technical services for the PIONEER2 clinical trial at the First Affiliated Hospital of Guangzhou Medical University.</p>\n<p>The contract value is approximately RMB4.09 million, underscoring continued commercial traction for Yidu Tech’s data-driven healthcare solutions.</p>\n<p>According to the announcement, Yidu Tech leverages artificial intelligence trained on real-world clinical data to streamline decision-making for physicians, pharmaceutical companies, insurers and patients. The PIONEER2 engagement reflects the company’s strategy of embedding proprietary AI capabilities across the healthcare value chain to accelerate precision medicine adoption in China.</p>\n<p>The Board is chaired by Executive Director Ms. Gong Yingying, with the voluntary announcement dated 28 April 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Yidu Tech secures RMB4.09 million contract to provide SMO technical services for PIONEER2 clinical trial</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nYidu Tech secures RMB4.09 million contract to provide SMO technical services for PIONEER2 clinical trial\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-28 21:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hong Kong–listed Yidu Tech announced that its affiliate, Yidu Cloud (Beijing) Technology Co., Ltd., has won the bid to deliver site management organization (SMO) technical services for the PIONEER2 clinical trial at the First Affiliated Hospital of Guangzhou Medical University.</p>\n<p>The contract value is approximately RMB4.09 million, underscoring continued commercial traction for Yidu Tech’s data-driven healthcare solutions.</p>\n<p>According to the announcement, Yidu Tech leverages artificial intelligence trained on real-world clinical data to streamline decision-making for physicians, pharmaceutical companies, insurers and patients. The PIONEER2 engagement reflects the company’s strategy of embedding proprietary AI capabilities across the healthcare value chain to accelerate precision medicine adoption in China.</p>\n<p>The Board is chaired by Executive Director Ms. Gong Yingying, with the voluntary announcement dated 28 April 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02158","symbol_name":"医渡科技","start_time":0,"source_url":"","article_id":"1192500227","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1192500227","pubTimestamp":1777382665,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hong Kong–listed Yidu Tech announced that its affiliate, Yidu Cloud (Beijing) Technology Co., Ltd., has won the bid to deliver site management organization (SMO) technical services for the PIONEER2...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02158":"医渡科技"},"translate_title":"医渡科技获得人民币409万元合同，为PIONEER2临床试验提供SMO技术服务","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02158":1},"content_text":"Hong Kong–listed Yidu Tech announced that its affiliate, Yidu Cloud (Beijing) Technology Co., Ltd., has won the bid to deliver site management organization (SMO) technical services for the PIONEER2 clinical trial at the First Affiliated Hospital of Guangzhou Medical University.\nThe contract value is approximately RMB4.09 million, underscoring continued commercial traction for Yidu Tech’s data-driven healthcare solutions.\nAccording to the announcement, Yidu Tech leverages artificial intelligence trained on real-world clinical data to streamline decision-making for physicians, pharmaceutical companies, insurers and patients. The PIONEER2 engagement reflects the company’s strategy of embedding proprietary AI capabilities across the healthcare value chain to accelerate precision medicine adoption in China.\nThe Board is chaired by Executive Director Ms. Gong Yingying, with the voluntary announcement dated 28 April 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"corporation,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}